...sell its 12% stake to Angelini and remains eligible for milestones. Other investors in Arvelle include NovaQuest Capital Management...

...the final $42.7 million tranche of Arvelle Therapeutics GmbH’s $133.3 million series A. Investors included NovaQuest Capital Management...

...been left behind,” said CEO Patrick Jordan, who is also a partner at Mycovia investor NovaQuest Capital Management...
...Durham, N.C. Technology: Oral antifungals Disease focus: Infectious Clinical status: Phase III Founded: 2018 by NovaQuest Capital Management...
...Richter plc, Jiangsu Hengrui Medicine Co. Ltd. Number of employees: 20 Funds raised: Undisclosed Investors: NovaQuest Capital Management...

...on Nov. 13, which Roivant says values the company at about $7 billion. New investors NovaQuest Capital Management...

...fourth equity financing, which Roivant says values the company at about $7 billion. New investors NovaQuest Capital Management...

...Sciences dermatology subsidiary of Roivant Sciences GmbH (Basel, Switzerland) received the $100 million investment from NovaQuest Capital Management...
...Basel, Switzerland NovaQuest Capital Management LLC, Raleigh, N.C. Business: Dermatology Alicia Parker GSK2894512, WBI-1001, tapinarof Roivant Sciences GmbH Aryl hydrocarbon receptor (AHR) NovaQuest Capital Management...

...forming subunit of the large conductance potassium channel. Dermavant received the $100 million investment from NovaQuest Capital Management...

...Pharmaxis filed suit in the Supreme Court of the State of New York alleging that NovaQuest Capital Management...

...Autoimmune Date announced: 2014-07-08 Note: Pharmaxis disclosed that on July 4 it received notice from NovaQuest Capital Management...

...NovaQuest Capital Management spun out of CRO Quintiles Transnational Corp. (NYSE:Q, Research Triangle Park, N.C.) in 2010. NovaQuest Capital Management...